193
Views
61
CrossRef citations to date
0
Altmetric
Review Article

Neurophysiological measures in amyotrophic lateral sclerosis: Markers of progression in clinical trials

, , , , &
Pages 17-28 | Received 10 Nov 2003, Accepted 04 Apr 2004, Published online: 10 Jul 2009

References

  • Kelly JJ, Thibodeau L, Andres PL, Finison LJ. Use of electrophysiological tests to measure disease progression in ALS therapeutic trials. Muscle Nerve. 1990;13:471–9.
  • Kent-Braun JA, Walker CH, Winer MW, Miller RG. Functional significance of upper and lower motor neuron impairment in amyotrophic lateral sclerosis. Muscle Nerve. 1998;21:762–8.
  • De Carvalho M, Swash M. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve. 2000;23:344–52.
  • Yuen E, Olney R. Longitudinal study of fibre density and motor unit estimates in patients with amyotrophic lateral sclerosis. Neurology. 1997;49:573–8.
  • Hansen S, Balantyne JP. A quantitative study of motor neurone disease. J Neurol Neurosurg Psychiatry. 1978;41:773–83.
  • Wang FC, Delwaide PJ. Number and relative size of thenar motor units in ALS patients: application of the adapted multiple point stimulation method. Electroencephalogr Clin Neurophysiol. 1998;109:36–43.
  • de Carvalho M. Compound muscle action potential. Amyotroph Lat Scler. 2002; 3(Suppl 1):S103–S4.
  • de Carvalho M, Lopes A, Scotto M, Swash M. Reproducibility of neurophysiological and myometric mea- surement in the ulnar nerve-abductor digiti minimi system. Muscle Nerve. 2001;24:1391–5.
  • Bigland B, Lippold OCJ. The relationship between force, velocity and integrated electrical activity in human muscle. J Physiol (Lond). 1954;123:214–24.
  • Bromberg M, Fries T. Forshew D, Tandan R. Electrophysiological endpoint measures in a multicentre ALS drug trial. J Neurol Sci. 2001;184:51–4.
  • Daube JR. Electrophysiological studies in the diagnosis and prognosis of motor neuron diseases. Neurol Clin. 1985;3:473–93.
  • de Carvalho M, Scotto M, Lopes A, Swash M. Clinical and neurophysiological evaluation of progression in amyotrophic lateral sclerosis. Muscle Nerve. 2003;28:630–3.
  • Brooke MH, Florence JM, Heller SL. Controlled trial of thyrotropin releasing hormone in amyotrophic lateral sclerosis. Neurology. 1986;36:146–51.
  • Mitsumoto H, Salgado ED, Negroski D. Amyotrophic lateral sclerosis: effects of acute intravenous and chronic subcutaneous administration of thyrotropin releasing hor- mone in controlled trials. Neurology. 1986;36:152–9.
  • The ALS CNTF treatment study (ACTS) Phase II–III Group: longitudinal electrodiagnostic studies in amyotrophic lateral sclerosis patients treated with recombinant human ciliary neurotrophic factor. Neurology. 1995; 45(Suppl 4): A448.
  • Kaji R, Kodama M, Imamura A, et al. Effect of ultra-high dose methylcobalamin on compound muscle action poten- tial in amyotrophic lateral sclerosis: a double-blind controlled study. Muscle Nerve. 1998;21:1775–1178.
  • Askmark H, Aquilonius SM, Gillberg PG, Liedholm LJ, Stalberg E, Wuopio R. A pilot trial of dextromethorphan in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1993;56:197–200.
  • Dengler R. Quantitative compound muscle action potential: Con. Amyotroph Lat Scler. 2002; 3(Suppl 1):S105–7.
  • de Carvalho M, Scotto M, Lopes A, Swash M. F-waves and the corticospinal lesion in amyotrophic lateral sclerosis. Amyotroph Lat Scler. 2002;3:131–6.
  • Drory VE, Kovach I, Groozman GB. Electrophysiological evaluation of upper motor involvement in amyotrophic lateral sclerosis. Amyotroph Lat Scler. 2001;2:147–52.
  • Sahrman SA, Norton BJ. The relationship of voluntary movement to spasticity in the upper motor neuron syn- drome. Ann Neurol. 1977;2:460–5.
  • de Carvalho, Scotto M, Lopes A, Swash M. Measurements of progression in ALS (abstract). Amyotroph Lat Scler. 2003; 4(Suppl 1):44.
  • Stalberg E, Schwartz MS, Trontelj JV. Single fibre electro- myography in various processes affecting the anterior horn cell. J Neurol Sci. 1974;24:403–15.
  • Stalberg E. Electromyographical studies of reinnervation in ALS. Adv Neurol. 1982;36:47–59.
  • Swash M, Schwartz MS. A longitudinal study of changes in motor units in motor neurone disease. J Neurol Sci. 1982;56:185–97.
  • Gooch CL, Harati Y. Longitudinal tracking of the same single motor unit in amyotrophic lateral sclerosis. Muscle Nerve. 1997;20:511–3.
  • Chan KM, Stashuk DN, Brown WF. A longitudinal study of the pathophysiological changes in single human thenar motor units in amyotrophic lateral sclerosis. Muscle Nerve. 1998;21:1714–23.
  • McComas AJ, Fawcett PRW, Campbell MJ, Sica REP. Electrophysiological estimation of the number of motor units within a human muscle. J Neurol Neurosurg Psychiatry. 1971;34:121–31.
  • Daube JR. Electrodiagnostic studies in amyotrophic lateral sclerosis. Muscle Nerve. 2000;23:1488–502.
  • Dantes M, McComas A. The extent and time course of motor neuron involvement in amyotrophic lateral sclerosis. Muscle Nerve. 1991;14:416–21.
  • McComas AJ. Motor unit estimation: anxieties and achieve- ments. Muscle Nerve. 1995;18:369–79.
  • Kadrie HA, Yates SK, Milner-Brown HS, Brown WF. Multiple point electrical stimulation of ulnar and median nerves. J Neurol Neurosurg Psychiatry. 1976;39:973–85.
  • Wang FC, Delwaide PJ. Number and relative size of thenar motor units estimated by an adapted multiple point stimulation method. Muscle Nerve. 1995;18:969–79.
  • Daube JR. Estimating the number of motor units in a muscle. J Clin Neurophysiol. 1995;12:585–94.
  • Shefner JM, Jillapalli D, Bradshaw DY. Reducing inter- subject variability in motor unit number estimation. Muscle Nerve. 1999;22:1457–80.
  • Brown WF, Strong MJ, Snow R. Methods for estimating numbers of motor units in biceps-brachialis muscles and losses of motor units with ageing. Muscle Nerve. 1988;11:423–32.
  • Stashuk DW, Doherty TJ, Kassam A, Brown WF. MUNE based on the automated analysis of F-responses. Muscle Nerve. 1994;17:881–90.
  • Felice KJ. A longitudinal study comparing thenar motor unit number estimate to other quantitative tests in patients with amyotrophic lateral sclerosis. Muscle Nerve. 1997;20:179–85.
  • Gooch CT, Harati Y. Motor unit number estimation, ALS and clinical trials. ALS. 2000;1:71–82.
  • Gooch CT, Pleitez M, Ciabarra T, Kaufmann P, Haraty Y. Motor unit survival in a controlled trial of xaliproden, with and without riluzole, for the treatment of ALS. Ann Neurol. 2001;50:S23.
  • Smith BE, Clarke JC, Litchy WJ. Longitudinal electrodiag- nosis studies in ALS patients treated with recombinant human ciliary neurotrophic factor. Neurology. 1995; 45(Suppl 4):A448.
  • Doherty TJ, Brown WF. A method for the longitudinal study of human thenar motor units. Muscle Nerve. 1994;17:1029–36.
  • Felice KJ. Thenar motor unit number estimates using the multiple point stimulation technique: reproducibility studies in ALS patients and normal subjects. Muscle Nerve. 1995;18:1412–6.
  • Gooch CL, Wagner T. Longitudinal S-MUAP tracking and MUNE: validity of a combined method (abstract). Muscle Nerve. 1998;21:1601.
  • Bromberg MB, Larson WL. Relationship between motor unit estimates and isometric strength in distal muscles in ALS/MND. J Neurol Sci. 1996;139(suppl):38–42.
  • Olney RK, Yuen EC, Engstrom JW. Statistical motor unit number estimation: reproducibility and sources of error in patients with amyotrophic lateral sclerosis. Muscle Nerve. 2000;23:193–7.
  • Lomen-Hoerth C, Olney RK. Comparison of multiple point and statistical motor unit number estimation. Muscle Nerve. 2000;23:1525–33.
  • Simmons Z, Stashuk D, Brown WF. MUNE using an automated F-response technique: reproducibility of results. Muscle Nerve. 1994;17:1120.
  • Bromberg ME. Motor unit estimation: reproducibility of the spike triggered averaging technique in normal and ALS subjects. Muscle Nerve. 1993;16:466–71.
  • Lomen-Hoerth C, Olney RK. Effect of recording window and stimulation variables on the statistical technique of motor unit number estimation. Muscle Nerve. 2001;24:1659–64.
  • Henderson RD, McClelland R, Daube JR. Effect of changing data collection parameters on statistical motor unit number estimates. Muscle Nerve. 2003;27:320–31.
  • Brown WF, Jaatoul N. Amyotrophic lateral sclerosis. Electrophysiological study (number of motor units and rate of decay of motor units). Arch Neurol. 1978;30:242–8.
  • Wang FC, Bouquiaux O, De Pasqua V, Delwaide PJ. Changes in motor unit numbers in patients with ALS: a longitudinal study using the adapted multiple point stimula- tion method. Amyotroph Lat Scler. 2002;3:31–8.
  • Felice KJ. Nerve conduction velocities of single thenar motor axons based on the automated analysis of F-waves in amyotrophic lateral sclerosis. Muscle Nerve. 1998;21:756–61.
  • Shefner JM, Cudkowitz ME, Brown RH. Comparison of incremental with multipoint MUNE in transgenic ALS mice. Muscle Nerve. 2002;25:39–42.
  • Olney RK, Lomen-Hoerth C. Motor unit number estima- tion (MUNE): how may it contribute to the diagnosis of ALS? Amyotroph Lat Scler. 2000; 1(Suppl 2):S41–S4.
  • Armon C, Brandstater ME. Motor unit number estimate- based rates of progression of ALS predict patient survival. Muscle Nerve. 1999;22:1571–5.
  • Rothwell JC, Hallet M, Berardelli A, Eisen A, Rossini P, Paulus W. Magnetic stimulation: motor evoked potentials. In: Deuschl G, Eisen A, editors. Recommendations for the practice of clinical neurophysiology: guidelines of the International Federation of Clinical Neurophysiology. 1999: 99.
  • Mills KR, Nithi KA. Corticomotor threshold is reduced in early sporadic amyotrophic lateral sclerosis. Muscle Nerve. 1997;20:1137–41.
  • de Carvalho M, Miranda PC, Jardim L, Gabriel F, Falca˜o F. Reproducibility of corticomotor threshold: some observa- tions. Muscle Nerve. 1999;22:538–9.
  • Eisen A, Pant B, Stewart H. Cortical excitability in amyotrophic lateral sclerosis: a clue to pathogenesis. Can J Neurol Sci. 1993;20:11–6.
  • Schwenkreis P, Liepert J, Witscher K, et al. Riluzole suppresses motor cortex facilitation in correlation to its plasma level. A study using transcranial magnetic stimula- tion. Exp Brain Res. 2000;135:293–9.
  • de Carvalho M, Evangelista T, Sales-Luis ML. The corticomotor threshold is not dependent on disease duration in amyotrophic lateral sclerosis (ALS). Amyotroph Lat Scler. 2002;3:39–42.
  • Zanette G, Tamburin S, Manganotti P, Refatti N, Forgione A, Rizzuto N. Different mechanisms contribute to motor cortex hyperexcitability in amyotrophic lateral sclerosis. Clin Neurophysiol. 2002;113:1688–97.
  • Ziemann U, Winter M, Reimers CD, Reimers K, Tergau F, Paulus W. Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis. Evidence from paired trans- cranial magnetic stimulation. Neurology. 1997;49:1292–8.
  • Caramia MD, Cicinelli P, Paradiso C, et al. Excitability changes of muscular responses to magnetic brain stimulation in patients with central motor disorders. Electroencephalogr Clin Neurophysiol. 1991;81:243–50.
  • Desiato MT, Bernardi G, Hagi HA, Boffa L, Caramia MD. Transcranial magnetic stimulation of motor pathways directed to muscles supplied by cranial nerves in amyo- trophic lateral sclerosis. Clin Neurophysiol. 2002;113:132–40.
  • Salerno A, Carlander B, Camu W, Georgesco M. Motor evoked potentials (MEPs): evaluation of the different types of responses in amyotrophic lateral sclerosis and primary lateral sclerosis. Electromyogr Clin Neurophysiol. 1996;36:361–8.
  • Eisen A, Shytbel W, Murphy K, Hoirch M. Cortical magnetic stimulation in amyotrophic lateral sclerosis. Muscle Nerve. 1990;13:146–51.
  • de Carvalho M, Miranda PC, Luis ML, Ducla-Soares E. Cortical muscle representation in amyotrophic lateral sclerosis patients: changes with disease evolution. Muscle Nerve. 1999;22:1684–92.
  • Weber M, Eisen A, Nakajima M. Corticomotoneuronal activity in ALS: changes in the peristimulus time histogram over time. Clin Neurophysiol. 2000a;111:169–77.
  • Zanette G, Tamburin S, Manganotti P, Refatti N, Forgione A, Rizzuto N. Changes in motor cortex inhibition over time in patients with amyotrophic lateral sclerosis. J Neurol. 2002;249:1723–8.
  • Brouwer B, Ashby P. Corticospinal projections to upper and lower limb spinal motor neurons in man. Electroencephalogr Clin Neurophysiol. 1990;76:509–19.
  • Chen R, Tam A, Butefisch C, et al. Intracortical inhibition and facilitation in different representations of the human motor cortex. J Neurophysiol. 1998;80:2870–81.
  • Kiers L, Cros D, Chiappa KH, Fang J. Variability of motor potentials evoked by transcranial magnetic stimulation. Electroencephalogr Clin Neurophysiol. 1993;89:415–23.
  • Uozumi T, Tsuji S, Murai Y. Motor potentials evoked by magnetic stimulation of the motor cortex in normal subjects and patients with motor disorders. Electroencephalogr Clin Neurophysiol. 1991;81:251–6.
  • Trompetto C, Caponnetto C, Buccolieri A, Marchese R, Abbruzzese G. Responses of masseter muscles to transcra- nial magnetic stimulation in patients with amyotrophic lateral sclerosis. Electroencephalogr Clin Neurophysiol. 1998;109:309–14.
  • Urban PP, Vogt T, Hopf HC. Corticobulbar tract involve- ment in amyotrophic lateral sclerosis: a transcranial magnetic stimulation study. Brain. 1998;121:1099–108.
  • Urban PP, Wicht S, Hopf HC. Sensitivity of transcranial magnetic stimulation of cortico-bulbar vs. cortico-spinal tract involvement in amyotrophic lateral sclerosis. J Neurol. 2001;248:850–5.
  • Weber M, Eisen A, Stewart H, Hirota N. The split hand in ALS has a cortical basis. J Neurol Sci. 2000;180:66–70.
  • Weber M, Eisen A. Magnetic stimulation of the central and peripheral nervous system. Muscle Nerve. 2002;25:160–75.
  • Ingram DA, Swash M. Central motor conduction time is abnormal in motor neurone disease. J Neurol Neurosurg Psychiatry. 1987;50:59–66.
  • Triggs WJ, Menkes D, Onorato J, et al. Transcranial magnetic stimulation identifies upper motor neuron involve- ment in motor neurone disease. Neurology. 1999;53:605–11.
  • Schriefer TN, Hess CW, Mills KR, Murray NM. Central motor conduction studies in motor neurone disease using magnetic brain stimulation. J Neurol Sci. 1989;74:431–7.
  • Claus D, Brunholzl C, Kerling FP, Henschel S. Transcranial magnetic stimulation as a diagnostic and prognostic test in amyotrophic lateral sclerosis. J Neurol Sci. 1995;1 29(suppl):30–4.
  • Mills KR, Nithi KA. Peripheral and central motor conduc- tion in amyotrophic lateral sclerosis. J Neurol Sci. 1998;159:82–7.
  • Cruz-Martinez A, Trejo JM. Transcranial magnetic stimula- tion in amyotrophic and primary lateral sclerosis. Electromyogr Clin Neurophysiol. 1999;39:285–8.
  • Pohl C, Block W, Traber F, et al. Proton magnetic resonance spectroscopy and transcranial magnetic stimula- tion for the detection of upper motor neuron degeneration in ALS patients. J Neurol Sci. 2001;190:21–7.
  • Schulte-Mattler WJ, Muller T, Zierz S. Transcranial magnetic stimulation compared with upper motor neuron signs in patients with amyotrophic lateral sclerosis. J Neurol Sci. 1999;170:51–6.
  • de Carvalho M, Turkman A, Swash M. Motor responses evoked by transcranial magnetic stimulation and peripheral nerve stimulation in the ulnar innervation in amyotrophic lateral sclerosis: the effect of upper and lower motor neuron lesion. J Neurol Sci. 2003;210:83–90.
  • Eisen A, Swash M. Clinical neurophysiology in ALS. Clin Neurophysiol. 2001;112:2190–201.
  • Prout AJ, Eisen AA. The cortical silent period and amyotrophic lateral sclerosis. Muscle Nerve. 1994;17:217–23.
  • Desiato MT, Caramia MD. Towards a neurophysiological marker of amyotrophic lateral sclerosis as revealed by changes in cortical excitability. Electroencephalogr Clin Neurophysiol. 1997;105:1–7.
  • Siciliano G, Manca ML, Sagliocco L, et al. Cortical silent period in patients with amyotrophic lateral sclerosis. J Neurol Sci. 1999;169:93–7.
  • Kujirai T, Caramia JC, Day BL, et al. Cortical-cortical inhibition in human motor cortex. J Physiol (London). 1992;471:501–19.
  • Ziemann U, Rothwell JC, Riding MC. Interaction between intracortical inhibition and facilitation in the human cortex. J Physiol (London). 1996;496:873–81.
  • Pierantozzi M, Palmieri MG, Marciani MG, et al. Effect of apomorphine on cortical inhibition in Parkinson’s disease patients: a transcranial magnetic stimulation study. Exp Brain Res. 2001;141:52–62.
  • Liepert J, Bar KJ, Maske U, et al. Motor cortex inhibition in Alzheimer’s disease. Clin Neurophysiol. 2001;112:1436–41.
  • Manganotti P, Tamburin S, Zanette G, et al. Hyperexcitable cortical responses in progressive myoclonic epilepsy: a transcortical magnetic stimulation study. Neurology. 2001;57:1793–9.
  • Sandbrink F, Syed NA, Fuji K, et al. Motor excitability in stiff person syndrome. Brain. 2000;133:2231–9.
  • Yokota T, Yoshino A, Inaba A, et al. Double cortical stimulation in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1996;61:596–600.
  • Sommer M, Tergau F, Wischer S, et al. Riluzole does not have an acute effect on motor thresholds and intracortical excitability in amyotrophic lateral sclerosis. J Neurol. 1999; 246(Suppl 3):22–6.
  • Stefan K, Kunesch E, Benecke R, Classen J. Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis. Ann Neurol. 2001;49:536–9.
  • Peinemann A, Lehner C, Conrad B, et al. Age-related decrease in paired pulse intracortical inhibition in the human primary motor cortex. Neurosci Letts. 2001;313:33–6.
  • Boroojerdi B, Kopylev L, Battaglia F, et al. Reproducibility of intracortical inhibition and facilitation using a paired pulse paradigm. Muscle Nerve. 2000;23:1594–7.
  • Ziemann U, Steinhoff BJ, Lonnecker S, et al. Inhibition of human motor cortex by ethanol. Brain. 1995;118:1437–46.
  • Ziemann U, Lonnecker S, Steinhoff BJ, et al. The effect of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol. 1996;40:367–78.
  • Ziemann U, Lonnecker S, Steinhoff BJ. The effect of lorazepam on motor cortex excitability in man. Exp Brain Res. 1996;109:127–35.
  • Manganotti P, Bortolomasi M, Zanette G, et al. Intravenous clomipramine decreases excitability of human motor cortex: a study with paired magnetic stimulation. J Neurol Sci. 2001;184:27–32.
  • Liepert J, Schardt S, Weiller C. Orally administered atropine enhances motor cortex excitability: a transcranial magnetic stimulation study in human subjects. Neurosci Letts. 2001;300:149–52.
  • Magistris MR, Rosler KM, Truffert A, Landis T, Hess CW. A clinical study of motor evoked potentials using a triple stimulation technique. Brain. 1999;122:265–79.
  • Rosler KM, Truffert A, Hess CW, Magistris MR. Quantification of upper motor neuron loss in amyotrophic lateral sclerosis. Clin Neurophysiol. 2000;111:2208–18.
  • Devanne H, Lavoie BA, Capaday C. Input-output proper- ties and gain changes in the human corticospinal pathway. Exp Brain Res. 1997;114:329–38.
  • Hess CW, Mills KR, Murray NM. Responses in small hand muscles from magnetic stimulation of the human brain. J Physiol (London). 1987;388:397–419.
  • de Noordhout AM, Rapisarda G, Bogacz D, et al. Corticomotoneuronal synaptic connections in normal man: an electrophysiological study. Brain. 1999;122:1327–40.
  • Mills KR. Corticomotoneuronal PSTH studies [editorial; comment]. Muscle Nerve. 1999;22:297–8.
  • Awiszus F, Feistner H. Abnormal EPSPs evoked by magnetic brain stimulation in hand muscle motor neurons of patients with amyotrophic lateral sclerosis. Electroencephalogr Clin Neurophysiol. 1993;89:408–14.
  • Eisen A, Entezari-Taher M, Stewart H. Cortical projections to spinal motor neurons: changes with ageing and amyo- trophic lateral sclerosis. Neurology. 1996;46:1396–404.
  • Kohara N, Kaji R, Kojima Y, et al. Abnormal excitability of the corticospinal pathway in patients with amyotrophic lateral sclerosis: a single motor unit study using transcranial magnetic stimulation. Electroencephalogr Clin Neurophysiol. 1996;101:32–41.
  • Nakajima M, Eisen A, Stewart H. Diverse abnormalities of corticomotoneuronal projections in individual patients with amyotrophic lateral sclerosis. Electroencephalogr Clin Neurophysiol. 1997;105:451–57.
  • Weber M, Eisen A. Assessment of upper and lower motor neurons in Kennedy’s disease: implications for corticomo- toneuronal PSTH studies [see comments]. Muscle Nerve. 1999;22:299–306.
  • Fetz EE, Gustafsson B. Relation between shapes of post- synaptic potentials and changes in firing probability of cat motor neurons. J Physiol (Lond). 1983;341:387–410.
  • Day BL, Rothwell JC, Thompson PD, et al. Motor cortex stimulation in intact man. 2. Multiple descending volleys. Brain. 1987;110:1191–209.
  • Ellaway PH. Cumulative sum technique and its application to the analysis of peristimulus time histograms. Electroencephalogr Clin Neurophysiol. 1978;45:302–04.
  • Weber M, Eisen A. Peristimulus time histograms (PSTHs): amarker for upper motor neuron involvement in ALS? Amyotroph Lat Scler. 2000; 1(Suppl 2):S51–S6.
  • Kohara N, Kaji R, Kojima Y, Kimura J. An electrophysio- logical study of the corticospinal projections in amyotrophic lateral sclerosis. Clin Neurophysiol. 1999;110:1123–32.
  • Weber M, Eisen A, Stewart HG, Andersen PM. Preserved slow conducting corticomotoneuronal projections in amyo- trophic lateral sclerosis with autosomal recessive D90A Cu/ Zn-superoxide dismutase mutation [in process citation]. Brain. 2000;123:1505–15.
  • Mills KR. Motor neurone disease. Studies of the corticosp- inal excitation of single motor neurons by magnetic brain stimulation. Brain. 1995;118:971–82.
  • Nakajima M, Eisen A, McCarthy R, Olney RK, Aminoff MJ. Reduced corticomotoneuronal excitatory postsynaptic potentials (EPSPs) with normal Ia afferent EPSPs in amyotrophic lateral sclerosis. Neurology. 1996;47:1555–61.
  • Nakajima M, Eisen A, Stewart H. Comparison of cortico- motoneuronal EPSPs and macro-MUPs in amyotrophic lateral sclerosis. Muscle Nerve. 1998;21:18–24.
  • Chan KM, Doherty TJ, Andres LP, et al. Longitudinal study of the contractile and electrical properties of single human thenar motor units. Muscle Nerve. 1998;21:839–49.
  • Brown WF, Doherty TJ, Chan M, Andres A, Provost SM. Human motor units in health and disease. Muscle Nerve. 2000;9:S7–S18.
  • Chan KM, Doherty TJ, Brown WF. Contractile properties of human motor units in health, ageing and disease. Muscle Nerve. 2001;24:1113–33.
  • Dengler R, Konstanzer A, Ku¨ ther G, Wolf W, Hesse S, Struppler A. Amyotrophic lateral sclerosis: Macro-EMG and twitch forces of single motor units. Muscle Nerve. 1990;13:545–50.
  • Stalberg E, Fawcett PRW. Macro-EMG in healthy subjects of different ages. J Neurol Neurosurg Psychiatry. 1982;45:870–8.
  • Stein RB, French AS, Mannard A, Yemm R. New methods for analysing muscle function in man and animals. Brain Res. 1972;40:187–92.
  • Heinze HJ, Elger CE, Schubert W, Kunz WS. Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain. 2000;123:1339–48.
  • Swash M. What does the neurologist expect from clinical neurophysiology? Muscle And Nerve. 2002; 25(Suppl - Stalberg Festschrift): S13–S8.
  • Brooks BR. Amyotrophic Lateral Sclerosis Scale: guidelines for administration and scoring. In: Herndon RM, editor. Handbook of Neurologic Rating Scales. New York: Demos Vermande, 1997: 27–80.
  • Kalra S, Arnold D. Neuroimaging in amyotrophic lateral sclerosis. Amyotroph Lat Scler. 2003;4:243–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.